合成生物学与绿色生物制造·2025-11-11 09:42Core Insights - The Ministry of Industry and Information Technology (MIIT) of China has released two significant documents regarding the development of biological manufacturing, focusing on high-performance bioreactors and pilot-scale platforms, which aim to advance this emerging productive force in the industry [2][11]. Summary by Sections High-Performance Bioreactors - On November 4, MIIT published a notice listing the selected units for the innovation tasks related to high-performance bioreactors, with 9 key bioreactors and 23 leading universities, research institutes, and enterprises included in the list [2][4]. - Notable participants include companies and institutions such as Womei Biotech, the Chinese Academy of Sciences Tianjin Institute of Industrial Biotechnology, and East China University of Science and Technology [2][5]. Pilot-Scale Platforms - On November 10, MIIT announced the first batch of units selected for the biological manufacturing pilot-scale capability construction platform, comprising 43 units [2][8]. - Among these, 12 units received ratings of four stars or above, including Tianjin University Frontier Research Institute of Synthetic Biology and Beijing University of Chemical Technology Qinhuangdao Bohai Biological Industry Research Institute [3][9]. Key Participants - The list of selected units for high-performance bioreactors includes various leading organizations such as: - Womei Biotech - East China University of Science and Technology - Dibeier Biotechnology - Chutian Technology [5][6]. - The pilot-scale platform includes institutions like: - Beijing Zhaoyan Biotechnology Co., Ltd. - Tianjin University - Chinese Academy of Sciences Tianjin Institute of Industrial Biotechnology [9][10].